yandex
zenasbio
Страна
США
Зарплата
219 200 $ – 274 000 $
+500% приглашений

Откликайтесь
на вакансии с ИИ

Ускорим процесс поиска работы
SeniorУдалённоПолная занятость

Senior Director, Pricing & Contracting

Оценка ИИ

Отличная вакансия в перспективной биотехнологической компании на стадии клинических испытаний. Высокий уровень компенсации, прозрачный диапазон зарплаты и возможность напрямую влиять на коммерческий успех инновационных препаратов.


Вакансия из Quick Offer Global, списка международных компаний
Пожаловаться

Сложность вакансии

ЛегкоСложно
Оценка ИИ

Высокий уровень сложности обусловлен требованием 12-летнего опыта в индустрии и глубокой экспертизы в специфических аспектах рынка США (GTN, AMP, Best Price). Роль подразумевает стратегическую ответственность за запуск новых продуктов на высококонкурентном рынке.

Анализ зарплаты

Медиана250 000 $
Рынок210 000 $ – 290 000 $
Оценка ИИ

Предложенная зарплата ($219k - $274k) полностью соответствует рыночным стандартам для позиций уровня Senior Director в биофармацевтическом секторе США, особенно в биотехнологических хабах вроде Массачусетса. Дополнительные бонусы и опционы делают предложение еще более конкурентоспособным.

Сопроводительное письмо

I am writing to express my strong interest in the Senior Director, Pricing & Contracting position at Zenas BioPharma. With over 12 years of experience in the biopharmaceutical industry and a proven track record in developing U.S. pricing strategies for specialty therapies, I am eager to bring my expertise in gross-to-net (GTN) modeling and payer contracting to your growing team. My background aligns perfectly with Zenas' mission to commercialize transformative therapies like obexelimab and orelabrutinib.

Throughout my career, I have successfully led launch pricing recommendations and managed complex rebate structures with PBMs and national payer organizations. I am particularly drawn to Zenas because of your 'TRUE Innovation' values and the unique opportunity to shape the market access landscape for a late-stage clinical portfolio. I am confident that my analytical skills and cross-functional leadership experience will contribute significantly to Zenas' commercial success and financial objectives.

+250% к просмотрам

Составьте идеальное письмо к вакансии с ИИ-агентом

Составьте идеальное письмо к вакансии с ИИ-агентом

Откликнитесь в zenasbio уже сейчас

Присоединяйтесь к лидеру в области иммунологии и определите стратегию ценообразования для инновационных препаратов — откликнитесь сегодня!

Описание вакансии

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas is advancing two late-stage, potential franchise molecules, obexelimab and orelabrutinib. Obexelimab, Zenas’ lead product candidate, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimab’s unique mechanism of action and self-administered, subcutaneous injection regimen may broadly and effectively address the pathogenic role of B cell lineage in chronic autoimmune disease. Orelabrutinib is a potentially best-in-class, highly selective CNS-penetrant, oral, small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with the potential to address compartmentalized inflammation and disease progression in Multiple Sclerosis (MS). Zenas’ earlier stage programs include a preclinical, potentially best-in-class, oral, IL-17AA/AF inhibitor, and a preclinical, potentially best-in-class, oral, brain-penetrant, TYK2 inhibitor.

We are seeking top talent who share our commitment to patients and have a track record of success in acquiring, developing and commercializing products across the globe. Our colleagues have an opportunity to engage in a fast-paced learning environment and experience individual and organizational success as we work towards becoming a global immunology and autoimmune disease leader, while living our values of Transparency, Relationships, Urgency, Excellence and Innovation – TRUE Innovation!

Position Summary:

The Senior Director, Pricing & Contracting is responsible for developing and leading the U.S. pricing and contracting strategy to support optimal market access, reimbursement, and financial performance for Zenas BioPharma’s portfolio, including development of contracting strategies with national/regional payer organizations, PBMs, and government payer segments.  Reporting to the Vice President, U.S. Market Access, this role will lead the development of pricing strategy, gross-to-net modeling, and payer contracting strategies that support both product launch planning and lifecycle management.

The Senior Director will play a key role in establishing launch pricing strategy while also overseeing ongoing pricing governance, access financial modeling, and contracting frameworks with payer organizations, pharmacy benefit managers (PBMs), and other healthcare stakeholders. This individual will work closely with the Payer Strategy team to support contract negotiations and ensure pricing and contracting decisions align with overall market access strategy and company financial objectives.

This role will collaborate cross-functionally with Finance, Market Access, Legal, Compliance, Medical Affairs, and Commercial leadership to evaluate pricing scenarios, inform access strategy decisions, and support the successful commercialization of Zenas therapies.

This role offers a unique opportunity to shape pricing and contracting strategy in preparation for upcoming product launches while supporting long-term access and financial performance for the Zenas portfolio.

Key Responsibilities:

  • Lead the development and execution of U.S. pricing strategy, including launch price recommendations and lifecycle pricing management for Zenas BioPharma’s portfolio.
  • Develop and manage gross-to-net (GTN) models that support financial forecasting, access strategy decisions, and pricing scenario planning.
  • Design and implement payer contracting strategies, including rebate structures and contracting frameworks with pharmacy benefit managers (PBMs), national payer organizations, and regional health plans.
  • Partner with the Payer Strategy team to support contract negotiations and ensure pricing and rebate strategies align with payer coverage objectives.
  • Lead financial modeling and pricing scenario analyses to evaluate the impact of pricing and contracting strategies on market access, reimbursement, and overall company financial performance.
  • Collaborate closely with Finance to ensure pricing assumptions, GTN forecasts, and contracting scenarios are accurately reflected in financial planning and forecasting models.
  • Monitor competitive pricing dynamics, payer contracting trends, and reimbursement environments to inform pricing strategy and market access planning.
  • Support the development of pricing governance processes and provide strategic recommendations to senior leadership regarding pricing decisions and contracting strategies.
  • Provide strategic pricing insights to support launch planning, payer engagement strategy, and long-term market access objectives.
  • Provide strategic oversight of government pricing considerations, including AMP, Best Price, Medicaid rebate implications, and 340B pricing impacts, ensuring pricing and contracting strategies align with regulatory requirements.
  • Partner with Legal and Compliance to ensure pricing and contracting practices adhere to regulatory requirements and company compliance standards.
  • Collaborate cross-functionally with Market Access, Commercial, Medical Affairs, HEOR, and Finance teams to ensure alignment between pricing strategy, access strategy, and commercial objectives.
  • Support the evaluation of pricing and contracting strategies across different payer segments, including commercial and government payer environments

Qualifications:

  • Minimum of 12+ years of experience in the pharmaceutical or biotechnology industry, including at least 7+ years in Pricing, Contracting, Market Access, or Managed Markets roles.
  • Demonstrated experience developing U.S. pricing strategy, including launch pricing recommendations and lifecycle pricing management for specialty or rare disease therapies.
  • Proven experience developing and managing gross-to-net (GTN) models to support financial forecasting, pricing scenario planning, and contracting strategy.
  • Demonstrated experience designing and implementing payer contracting strategies, including rebate structures and negotiations with pharmacy benefit managers (PBMs), national payer organizations, government payers and regional health plans.
  • Strong understanding of U.S. pharmaceutical pricing dynamics, including WAC strategy, payer rebates, contracting frameworks, and market access considerations.
  • Experience evaluating government pricing implications including AMP, Best Price, Medicaid rebate exposure, and 340B pricing considerations.
  • Experience supporting product launches or late-stage pipeline assets strongly preferred.
  • Strong financial modeling and analytical skills with the ability to translate complex pricing and contracting scenarios into strategic recommendations.
  • Demonstrated ability to collaborate cross-functionally with Market Access, Finance, Legal, Compliance, Medical Affairs, and Commercial teams.
  • Experience supporting pricing governance processes and cross-functional pricing decision frameworks preferred.
  • Bachelor’s degree required; advanced degree (MBA, MPH, PharmD or similar) preferred.
  • Strong leadership, communication, and executive presentation skills.
  • Ability to operate effectively in a fast-paced and collaborative biotech environment.
  • Willingness to travel as required to support contracting discussions and internal planning

#LI-Remote

The position is eligible for a competitive compensation and benefits package.

Zenas is committed to fair and equitable compensation practices. The base salary pay range for this role is $219,200 to 274,000. Actual compensation packages will depend on various factors, including, but not limited to depth of experience, education, skillset, overall performance and/or location.

Zenas believes in providing a competitive compensation and benefits package to all employees. Our base salary is just one component of Zenas’ competitive total rewards strategy that also includes annual performance bonus, equity, full range of benefits and other incentive compensation plans.

Zenas BioPharma is proud to be an equal opportunity employer. We are committed to fostering an environment where diversity is valued.  All qualified applicants will receive consideration for employment based on merit, qualifications and the needs of the business.

+400% к собеседованиям

Создайте идеальное резюме с помощью ИИ-агента

Создайте идеальное резюме с помощью ИИ-агента

Навыки

  • Pricing Strategy
  • Market Access
  • Financial Modeling
  • Gross-to-Net Modeling
  • Payer Contracting
  • PBM Management
  • Government Pricing
  • Medicaid Rebates
  • 340B Pricing
  • Commercialization
  • Strategic Planning

Возможные вопросы на собеседовании

Проверка опыта вывода новых продуктов на рынок США.

Опишите ваш опыт разработки стратегии ценообразования при запуске препарата (WAC strategy) для орфанных или специализированных заболеваний.

Оценка технических навыков финансового моделирования.

Как вы подходите к построению и управлению моделями Gross-to-Net (GTN) для прогнозирования влияния скидок и вычетов на чистую выручку?

Проверка знаний регуляторной среды США.

Каким образом вы учитываете требования по государственному ценообразованию (Medicaid Best Price, 340B) при разработке коммерческих контрактов с PBM?

Оценка навыков ведения переговоров и взаимодействия с плательщиками.

Расскажите о наиболее сложном случае переговоров по контракту с крупным PBM или национальным плательщиком. Каков был результат?

Проверка лидерских качеств и кросс-функционального взаимодействия.

Как вы выстраиваете взаимодействие между отделами финансов, юридическим департаментом и коммерческим блоком для обеспечения комплаенса и прибыльности стратегий?

Похожие вакансии

AI-native fintech startup
Не указана

Senior Finance Analyst

SeniorУдалённоРоссия
SQL · Financial Modeling · Acquiring · Visa/Mastercard Schemes · Reconciliation · Core Banking · EMI/PSP Regulation · Safeguarding · Fraud Detection · Chargebacks
+10 навыков
INCORE
Не указана

Старший специалист по управлению рисками

SeniorВ офисеАрмения
Risk Management · Financial Analysis · Reporting · Economics · Banking · Investment Management
+6 навыков
oscar
91 659 $ – 120 303 $

Senior Actuarial Analyst

SeniorУдалённоГрузия
Actuarial Science · Financial Modeling · Data Analysis · ACA Compliance · Benchmarking · SQL · Python · R · Health Insurance
+9 навыков
oscar
91 659 $ – 120 303 $

Senior Actuarial Analyst

SeniorУдалённоГрузия
Actuarial Modeling · Risk Adjustment · Financial Forecasting · Data Analysis · ACA Compliance · STEM · Automation
+7 навыков
praxisprecisionmedicines
85 000 $ – 105 000 $

Senior Accountant

SeniorУдалённоСША
Accounting · Financial Planning and Analysis · General Ledger · US GAAP · Accruals · Financial Reporting · Budgeting · Forecasting · Reconciliation
+9 навыков
netlify
78 000 $ – 110 000 $

Senior Accountant

SeniorУдалённоСША
GAAP · Accounting · Financial Reporting · Excel · SaaS · Payroll Accounting · Automation · AI · General Ledger · Reconciliation
+10 навыков
более 1000 офферов получено
4.9

1000+ офферов получено

Устали искать работу? Мы найдём её за вас

Quick Offer улучшит ваше резюме, подберёт лучшие вакансии и откликнется за вас. Результат — в 3 раза больше приглашений на собеседования и никакой рутины!

zenasbio
Страна
США
Зарплата
219 200 $ – 274 000 $